TinyGemsBreaks Archive

MondayApr 27, 2026 12:15 pm

TinyGemsBreaks – SEGG Media Corporation (NASDAQ: SEGG, LTRYW) Targets 2026 FIFA World Cup Launch for Sports.com Predict

SEGG Media (NASDAQ: SEGG, LTRYW) announced its Sports.com Predict platform is expected to go live ahead of the 2026 FIFA World Cup, positioning the Company to capitalize on heightened global fan engagement around the tournament. Designed as a scalable, transaction-based platform, Sports.com Predict aims to drive recurring revenue through fan participation in sports predictions, with a phased rollout underway as SEGG Media builds the platform into a long-term growth engine across major sporting events and geographies. To view the full press release, visit https://ibn.fm/JAKTa About SEGG Media Corporation Sports Entertainment Gaming Global Corporation (Nasdaq: SEGG, LTRYW) is a global sports,…

FridayApr 24, 2026 3:22 pm

TinyGemsBreaks – Rail Vision Ltd. (NASDAQ: RVSN) Integrating AI and Imaging to Redefine Train Safety Systems

Rail Vision (NASDAQ: RVSN) is poised for opportunity as the global train collision avoidance market is undergoing a dramatic transformation, driven by the convergence of advanced camera systems and artificial intelligence. The company is “developing proprietary AI-integrated sensing platforms designed to detect hazards in real time and ultimately enable fully autonomous train operations,” reads a recent article. “Israel-based Rail Vision has built its technology around the idea that the most dangerous moments for a train are the ones no one planned for. The company’s offerings have been described as AI-powered perception systems that allow rail operators to predict and prevent collisions, operating…

FridayApr 24, 2026 2:59 pm

TinyGemsBreaks – LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Unlocking New Potential in Precision Cancer Treatment

LIXTE Biotechnology Holdings (NASDAQ: LIXT) is advancing the precision oncology landscape, developing therapies that complement existing cancer treatments while integrating cutting-edge data solutions. “The company’s lead program, LB-100, is a novel small-molecule compound designed to enhance the efficacy of chemotherapy and radiation, aiming to improve patient outcomes while reducing treatment-related side effects,” reads a recent article. “By focusing on improving the therapeutic index of existing cancer modalities, the company is tackling a recurrent challenge in the field of oncology: maximizing treatment impact while cutting down risks to healthy tissue.” To view the full article, visit https://ibn.fm/EE6ya About LIXTE Biotechnology Holdings Inc. LIXTE…

FridayApr 24, 2026 2:00 pm

TinyGemsBreaks – SEGG Media Corporation (NASDAQ: SEGG, LTRYW) Launches Sports.com Predict Platform

SEGG Media (NASDAQ: SEGG, LTRYW) announced the launch of Sports.com Predict, marking its entry into the fast-growing prediction markets sector through its subsidiary Sports Predicts Limited. The platform, currently in development and expected to launch in summer 2026, will integrate prediction functionality into the Sports.com ecosystem, enabling the company to convert fan engagement into transactional activity and generate recurring, high-margin revenue through user-driven transaction fees. Building on recent acquisitions including Veloce Media Group and Quadrant, SEGG Media said the initiative leverages its large audience base to support scalable growth as global prediction market volumes continue to expand. To view the…

ThursdayApr 23, 2026 10:00 am

TinyGemsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) to Report First Quarter Fiscal Year 2026 Financial Results on May 12, 2026

D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave” or the “Company”), the only dual-platform quantum computing company providing both annealing and gate-model systems, software and services, today announced it will release its financial results for the first quarter of fiscal year 2026 ended March 31, 2026 on Tuesday, May 12, 2026 before market open. The press release will be available on the D-Wave Investor Relations website: https://ir.dwavequantum.com. In conjunction with this announcement, D-Wave will host a conference call on Tuesday, May 12, 2026, at 8:00 a.m. (Eastern Time), to discuss the Company’s financial results and business outlook. The live dial-in number is 1-833-890-9920 (domestic)…

ThursdayApr 23, 2026 9:50 am

TinyGemsBreaks – ParaZero Technologies Ltd. (NASDAQ: PRZO) Expands European Presence With Romania Reseller Agreement

ParaZero Technologies (NASDAQ: PRZO) announced it has signed a reseller agreement with Romania-based New Akord Security to market its DefendAir counter-drone system and provide training and local support, expanding its footprint across Europe and NATO-aligned markets. The agreement includes an initial demo kit purchase and planned live demonstration for Romanian defense officials at the BSDA exhibition in Bucharest, as the company builds momentum for its non-kinetic drone interception technology designed to protect military and civilian infrastructure. To view the full press release, visit https://ibn.fm/k6jKZ About ParaZero Technologies ParaZero Technologies Ltd. (Nasdaq: PRZO) is an aerospace defense company pioneering smart, autonomous solutions for…

FridayApr 17, 2026 2:14 pm

TinyGemsBreaks – Rail Vision Ltd. (NASDAQ: RVSN) Deploys AI, Thermal Imaging to Redefine Rail Safety

Amid increased demand for advanced collision-avoidance systems as rail networks grow more complex, Rail Vision’s (NASDAQ: RVSN) artificial-intelligence (“AI”)-powered electro-optical sensors are emerging as a direct technological response. “Rail Vision develops vision-based detection systems designed to improve railway safety and operational performance, offering real-time obstacle detection and situational awareness that align closely with evolving safety priorities across the industry,” reads a recent article. “Rail Vision’s AI-powered electro-optical sensor systems are designed to address key railway safety challenges by integrating wide-field and narrow-field electro-optic cameras to provide a complete ‘safety envelope’ around the train. The company’s solutions include the use of thermal cameras that…

FridayApr 17, 2026 1:27 pm

TinyGemsBreaks – LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Positions LB-100 as Novel Approach in Cancer Treatment Landscape

Boca Raton, Florida-based LIXTE Biotechnology Holdings (NASDAQ: LIXT) spent 2025 expanding its presence across multiple segments of oncology innovation. “The company is best known for its clinical-stage pharmaceutical pipeline built around LB-100, a first-in-class inhibitor of protein phosphatase 2A (‘PP2A’),” a recent article reads. “Rather than replacing established cancer therapies, LB-100 is designed to enhance their effectiveness. By inhibiting PP2A, the compound stimulates cell-cycle progression and interferes with DNA repair in cancer cells, potentially making tumors more responsive to chemotherapy and immunotherapy. LB-100 is currently being evaluated in multiple clinical programs targeting solid tumors with significant unmet medical need, including ovarian clear…

ThursdayApr 16, 2026 9:10 am

TinyGemsBreaks – Helus Pharma(TM) (NASDAQ: HELP) (Cboe CA: HELP) Appoints Dr. Ken Kramer SVP Medical Affairs

This NewsBreak has been disseminated on behalf of Helus Pharma and may include paid advertising. Helus Pharma(TM) (NASDAQ: HELP) (Cboe CA: HELP), a clinical-stage pharmaceutical company developing novel serotonergic agonists (“NSAs”), announced the appointment of Dr. Ken Kramer, PhD, as senior vice president of medical affairs, effective immediately. Kramer brings more than 20 years of neuroscience-focused medical affairs leadership, including roles at Bristol Myers Squibb, Karuna Therapeutics and AbbVie, and is expected to support Helus in advancing its pipeline and strengthening engagement with clinical and scientific stakeholders. To view the full press release, visit https://ibn.fm/FdEXH About Helus Pharma Helus Pharma(TM),…

WednesdayApr 15, 2026 9:55 am

TinyGemsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Reports Publication of TONMYA Pharmacokinetic Study in Peer-Reviewed Journal

Tonix Pharmaceuticals (NASDAQ: TNXP), a commercial-stage biotechnology company, announced the publication of a peer-reviewed study detailing the steady-state pharmacokinetic properties of TNX-102 SL, the sublingual formulation of cyclobenzaprine HCl marketed as TONMYA(R), in Clinical Pharmacology in Drug Development. The study, conducted in 60 healthy volunteers, demonstrated that the sublingual formulation achieves faster absorption, earlier peak plasma concentration and higher dose-normalized bioavailability compared to oral extended-release cyclobenzaprine, supporting its use for long-term bedtime dosing to target nonrestorative sleep in fibromyalgia, reduce pain and improve related symptoms. To view the full press release, visit https://ibn.fm/AX1hL Tonix Pharmaceuticals Holding Corp. Tonix Pharmaceuticals is…

Spotlighting undiscovered companies with enormous upside potential.

Contact us: (512) 354-7000

TinyGemsBreaks